Prevalence of Antibodies for the Hepatitis C Virus in the Lowland (Bajio) Region of Mexico

Cruz-Ruiz, M A; Díaz, Fernando López; Gonzalez-Ibarra, Fernando; Lara-Ortega, Christian; Guzman, Ana Laura Muñoz-Ledo; Patiño-López, Gloria A.

doi:10.1016/j.arcmed.2013.05.006

Cited by 3 publications

(1 citation statement)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, in many middle and low-income countries, the existence of a large amount of cases that acquired HCV due to unsafe health-care procedures or due to intravenous drugs use and contamination that took place by the end of the 20 th century, may increase the HCV complications and mortality in the coming years 11 . Previous studies in Mexico have shown that blood transfusion is the most frequent HCV transmission mechanism 3,12 and that HCV incidence and mortality rates had a mild increment in the past 13,14 . In this study, using administrative registers of the three main Health Institutions, which covers about 90% of the Mexican population with an overlapping coverage below 2% 15 ; we found a continuous decrease of HCV mortality and hospitalization rates during the 13-year period.…”

Section: Discussionmentioning

confidence: 99%

Hepatitis C in the three main health institutions in Mexico: a 13-year mortality and hospitalization analysis

Ascencio-Montiel

2020

Rev. Inst. Med. trop. S. Paulo

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Hepatitis C in the three main health institutions in Mexico: a 13-year mortality and hospitalization analysis

Ascencio-Montiel

2020

Rev. Inst. Med. trop. S. Paulo

View full text Add to dashboard Cite

A comprehensive update of the status of hepatitis C virus (HCV) infection in Mexico—A systematic review and meta-analysis (2008–2019)

Sedeño-Monge

Laguna-Meraz

Santos‐López

et al. 2021

Annals of Hepatology

View full text Add to dashboard Cite

An Update on Viral Hepatitis B and C in Mexico: Advances and Pitfalls in Eradication Strategies

Campos-Valdez,

Castro-García,

Ramos-Márquez

et al. 2024

Microorganisms

View full text Add to dashboard Cite

In Mexico, hepatitis B and C infections are a significant burden on the health system. The aim of this narrative review was to analyze the state of the art on hepatitis B and C in Mexico by searching and studying available data in academic articles and government reports and statements on epidemiology, prevention, treatment, and elimination strategies undertaken by the Mexican government. Even where the government has implemented a hepatitis B vaccination strategy to reduce its incidence, a very low proportion of people complete the vaccination schedule. Regarding hepatitis C, there is a National Elimination Program that emphasizes the importance of screening, diagnosis, and treatment focused on the population at risk. With the implementation of this program, more than a million fast tests have been carried out and the positive cases have been verified by viral load. Infected patients are tested to determine liver function, fibrosis stage, and coinfection with HBV and/or HIV. Patients without cirrhosis and/or coinfections are treated in first-level care centers, while those with cirrhosis and/or comorbidities are referred to specialists. The possibility of hepatitis C eradication in Mexico seems more likely than eradication of hepatitis B; however, major challenges remain to be overcome to reach both infections’ elimination.

show abstract

Prevalence of Antibodies for the Hepatitis C Virus in the Lowland (Bajio) Region of Mexico

Cited by 3 publications

References 14 publications

Hepatitis C in the three main health institutions in Mexico: a 13-year mortality and hospitalization analysis

Hepatitis C in the three main health institutions in Mexico: a 13-year mortality and hospitalization analysis

A comprehensive update of the status of hepatitis C virus (HCV) infection in Mexico—A systematic review and meta-analysis (2008–2019)

An Update on Viral Hepatitis B and C in Mexico: Advances and Pitfalls in Eradication Strategies

Contact Info

Product

Resources

About